Doctor of Veterinary Medicine (DVM), Juris Doctor (J.D.)
Robert Alderson
International Client Relations, US and European Patent Attorney
Robert is one of a very small number of intellectual property attorneys working at a European IP firm who has a law degree from the United States and is qualified to practice before both the United States Patent and Trademark Office and the European Patent Office. His responsibility at Berggren primarily involves international business development activities. In such capacity, Robert often writes and speaks on a variety of intellectual property-related topics, particularly concerning comparative IP law issues. In his professional capacity, Robert has a great deal of experience in patent prosecution, litigation, licensing, opinion letter-writing, and IP due diligence matters.
In addition, Robert is actively involved in supporting Berggren´s Brokerage team, in particular with respect to deals with entities in Asia and the United States. Prior to moving to Europe over 10 years ago, he worked in New York as an intellectual property attorney for 14 years, including over 10 years in the IP group of an AmLaw 100 law firm.
Services
IP licensing, Infringement analysis, Technology sales and licensing, IP strategy, IP portfolio analysis and management, Freedom to operate analysis (FTO), IP Due Diligence
Education
Speciality
International business development, Client management, Biotechnology, Biochemistry, Life sciences, Medical devices.
Technical fields
Biotechnology, Life Sciences, MedTech
Recent Posts By Robert Alderson
Breaking EPO News in G 1/21 - Video injured but apparently has not killed the in-person oral proceedings star
On Friday, 16 July 2021 the Enlarged Board of Appeal (“the EBA”) of the European Patent Office...
Read moreBreaking News: German Constitutional Court Clears Path for Ratification of European Unified Patent Court Agreement
In an order published on Friday 9 July 2021, the Second Senate of the German Federal Constitutional...
Read moreFocus on Brexit
The United Kingdom exited from the European Union on 31 January 2020. Pursuant to the Withdrawal...
Read moreFocus on Priority Claims in Europe
In a highly anticipated decision, the European Patent Office (“EPO”) Board of Appeal, on 17 January...
Read more